(MedPage Today) -- Patients with intracerebral hemorrhage showed improved outcomes when given fingolimod (Gilenya), the oral multiple sclerosis drug, compared with standard care alone in a small trial, researchers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment